News Daily News MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission Todd Neale December 29, 2021
News Daily News No Uptick in CVD Events After COVID-19 Vaccination in Older Adults Michael O'Riordan November 29, 2021
News Daily News ESC Releases Guidance on How to Address CVD in COVID-19 Era Yael L. Maxwell November 17, 2021
News Daily News Could a Coronary Calcium Test Rule Out CAD in Chest Pain? Michael O'Riordan October 21, 2021
News Features When the Time Comes to Stop Oral Anticoagulation: Options and Obstacles Todd Neale September 28, 2021
News Daily News In Adults, CV Pathology Dominates COVID-19 Multisystem Inflammatory Syndrome Shelley Wood September 23, 2021
News Daily News Score May Help Guide VITT Management After COVID-19 Vaccination Todd Neale September 23, 2021
News Daily News Long-term Anticoagulation After Unprovoked VTE: New Insights Shelley Wood September 13, 2021
News Conference News SCCT 2021 COVID-19’s Effects on Cardiac Imaging Protocols, Perspectives Still Unfolding Yael L. Maxwell July 23, 2021
News Daily News Risk Stratification Before Noncardiac Surgery Won’t Catch All Myocardial Injury Yael L. Maxwell June 28, 2021
News Daily News Papers Probe Temporal Link Between COVID-19 Vaccines and Myocarditis Michael O'Riordan June 17, 2021
News Conference News ACC 2021 ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19 Todd Neale May 17, 2021
News Daily News VTE Risk Higher After Oxford/AstraZeneca COVID-19 Vaccine, Study Affirms Todd Neale May 06, 2021
News Daily News Blood Clots After COVID-19 Vaccination Linked to Immune Response: UK Report Michael O'Riordan April 16, 2021
News Daily News Papers Confirm Rare Thrombocytopenia Link to AstraZeneca Vaccine Shelley Wood April 09, 2021
News Daily News Observational Study Supports Continuing Oral Anticoagulation During PCI Michael O'Riordan April 06, 2021